Fluidigm's Q4 Revenues Climb 36 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Reporting as a public company for the first time, Fluidigm today said that its fourth-quarter revenues increased 36 percent while it trimmed its net loss year over year.

The South San Francisco-based microfluidics and sample preparation technologies firm brought in total revenues of $10.4 million for the three months ended Dec. 31, 2010, compared to $7.6 million for the fourth quarter of 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.